Gsk (GSK) Divestments (2009 - 2026)
Gsk (GSK) posted quarterly Divestments of $330.3 million for Q1 2026, up 26324.98% year-over-year from N/an in Q1 2025, and up 956.27% quarter-over-quarter from -$38.6 million in Q4 2025.
Gsk (GSK) Divestments (2009 - 2026) Analysis & Trends
Gsk's Divestments history runs 18 years deep, the most recent figure standing at $330.3 million for Q1 2026.
- In Q1 2026, Divestments rose 26324.98% year-over-year to $330.3 million; the TTM figure through Mar 2026 stood at $277.6 million (up 413.31% YoY), while the FY2025 annual figure was -$35.6 million, down 54.72% from the prior year.
- Divestments for Q1 2026 stood at $330.3 million, up from -$38.6 million in the prior quarter.
- The five-year high for Divestments was $330.3 million in Q1 2026, with the low at -$38.6 million in Q4 2025.
- The 5-year median for Divestments is -$3.8 million (2024), against an average of $36.2 million.
- The sharpest annual moves came in 2023 and 2026: Divestments tumbled 643.51% in 2023, then surged 26324.98% in 2026.
- Gsk's Divestments stood at -$14.1 million in 2022, then surged by 611.45% to $72.0 million in 2023, then plunged by 117.83% to -$12.8 million in 2024, then tumbled by 200.54% to -$38.6 million in 2025, then jumped by 956.27% to $330.3 million in 2026.
- Business Quant data shows GSK's Divestments at $330.3 million in Q1 2026, -$38.6 million in Q4 2025, and -$1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 1.88 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330.30 Mn |
| Dec 31, 2025 | -38.57 Mn |
| Mar 31, 2025 | -1.26 Mn |
| Dec 31, 2024 | -12.84 Mn |
| Mar 31, 2024 | -3.81 Mn |
| Dec 31, 2023 | 71.99 Mn |
| Mar 31, 2023 | -7.29 Mn |
| Dec 31, 2022 | -14.08 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | -25.61 Mn |
| Mar 31, 2021 | 4.14 Mn |
| Dec 31, 2020 | 312.95 Mn |
| Sep 28, 2020 | 300.05 Mn |
| Mar 31, 2020 | 187.15 Mn |
| Dec 31, 2019 | 15.43 Mn |
| Sep 30, 2019 | -17.27 Mn |
| Mar 31, 2019 | -29.94 Mn |
| Dec 31, 2018 | 37.32 Mn |
| Mar 31, 2018 | -12.52 Mn |
| Dec 31, 2017 | 296.07 Mn |